What is BLSIF stock price today?

BLSIF (BLSIF) stock is trading at $0.06 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is BLSIF stock going up or down today?

BLSIF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy BLSIF stock now?

The decision to buy BLSIF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is BLSIF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for BLSIF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is BLSIF stock overvalued or undervalued?

BLSIF currently trades at a P/E ratio of 1.50, which may suggest attractive valuation. Our DCF calculator provides intrinsic value estimates to help determine if BLSIF is fairly priced.

What is BLSIF's P/E ratio?

BLSIF has a price-to-earnings (P/E) ratio of 1.50, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is BLSIF's market cap?

BLSIF (BLSIF) has a market capitalization of $0.01 billion, making it a small-cap stock.

What is BLSIF's price to book ratio?

BLSIF trades at a price-to-book (P/B) ratio of 0.78, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does BLSIF pay dividends?

BLSIF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is BLSIF's dividend yield?

BLSIF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is BLSIF stock a good long-term investment?

BLSIF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is BLSIF's revenue growth rate?

BLSIF has shown revenue growth of -0.6% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Yes, BLSIF is profitable with a profit margin of 129.9%. This indicates the company generates 129.9 cents of profit for every dollar of revenue.

What are the risks of investing in BLSIF?

Key risks for BLSIF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does BLSIF compare to its competitors?

Compare BLSIF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize BLSIF's performance and positioning.

What is BLSIF's stock price target for 2026?

Our AI model provides price targets for BLSIF based on fundamental analysis: Bull case $0.08 (+30%), Base case $0.07 (+15%), Bear case $0.05 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about BLSIF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for BLSIF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is BLSIF's next earnings report?

BLSIF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

BLSIF - BLSIF

NYSE * Healthcare * Biotechnology

$0.06

+$0.00 (+0.00%)

About BLSIF

Britannia Life Sciences Inc. engages in the product testing, safety assessment, and manufacturing services in the United Kingdom and internationally. It serves cosmetics, consumer packaged and household goods, and nutraceutical industries. The company is headquartered in Toronto, Canada.

BLSIF Key Statistics

Market Cap

$9.74M

P/E Ratio

1.50

P/B Ratio

0.78

EPS

$0.04

Revenue Growth

-0.6%

Profit Margin

129.9%

How BLSIF Compares to Peers

BLSIF has the lowest P/E ratio in Biotechnology, suggesting it may be the most undervalued

BLSIF has the highest profit margins in Biotechnology

BLSIF is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

of 6

Growth Rank

of 6

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
BLSIF(This stock)	$9.74M	1.5	-1%	129.9%	-
AMGNAmgen Inc	$191.53B	24.9	0%	0.2%	vs AMGN
GILDGilead Sciences	$170.84B	20.3	0%	0.3%	vs GILD
VRTXVertex Pharmaceuticals	$112.22B	28.8	0%	0.3%	vs VRTX
REGNRegeneron Pharmaceuticals	$79.35B	18.1	0%	0.3%	vs REGN
BIIBBiogen Inc	$26.91B	20.9	-0%	0.1%	vs BIIB

BLSIF Company Information

Headquarters: 120 Adelaide Street West, Toronto, ON, Canada, M5H 1T1, undefined
Website: britannia.life
Sector: Healthcare
Industry: Biotechnology

Data Updated: April 21, 2026 at 6:53 PM EDT

Ready to invest in BLSIF?

Commission-free trading available. Affiliate links.

Upcoming Events for BLSIF

Dashboard

Enter a ticker to analyze